29377

29377
Busse WW, Bleecker ER, FitzGerald JM, et al. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med 2019; 7(1):46–59. DOI: 10.1016/S2213-2600(18)30406-5. http://www.ncbi.nlm.nih.gov/pubmed/30416083
Einstellungen
29377
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 25.01.2021 | 18:44 Uhr